SciClone Pharmaceuticals (Holdings) Limited

SEHK:6600 Stock Report

Mkt Cap: HK$6.7b

SciClone Pharmaceuticals (Holdings) Financial Health

How is SciClone Pharmaceuticals (Holdings)'s financial position?

Financial Health Score


Financial Health Score 5/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: 6600's short term assets (CN¥3.6B) exceed its short term liabilities (CN¥912.9M).

Long Term Liabilities: 6600's short term assets (CN¥3.6B) exceed its long term liabilities (CN¥832.6M).

Debt to Equity History and Analysis

Debt Level: 6600 has more cash than its total debt.

Reducing Debt: 6600's debt to equity ratio has increased from 0% to 46.6% over the past 5 years.

Debt Coverage: 6600's debt is well covered by operating cash flow (103.3%).

Interest Coverage: 6600's interest payments on its debt are well covered by EBIT (53.4x coverage).

Balance Sheet

Discover healthy companies